Recent CDC FluSurv-NET data show the cumulative influenza-associated hospitalization rate reaching 86.3 per 100,000 by Week 18 ending May 9, 2026, with weekly rates already down to 0.2 per 100,000 amid sharply declining national activity. This post-peak stabilization, following a season with the third-highest cumulative burden since 2010-11, positions the rate for Week 22 ending late May firmly in the 85–90 range, as additional admissions in the final weeks of surveillance are expected to remain negligible. Market-implied odds above 98% reflect this established downward trajectory from official surveillance, though an unexpected late-season uptick in transmission could still push the final cumulative figure modestly higher.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Flu Hospitalization Rate Week 22, 2026?
Flu Hospitalization Rate Week 22, 2026?
85–90 98.4%
95–100 <1%
<80 <1%
90–95 <1%
新規
新規
2026/06/12
<80
<1%
80–85
<1%
85–90
98%
90–95
<1%
95–100
1%
100+
<1%
85–90 98.4%
95–100 <1%
<80 <1%
90–95 <1%
新規
新規
2026/06/12
<80
$418 Vol.
<1%
80–85
$426 Vol.
<1%
85–90
$1,635 Vol.
98%
90–95
$380 Vol.
<1%
95–100
$391 Vol.
1%
100+
$387 Vol.
<1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluSurv-NET data show the cumulative influenza-associated hospitalization rate reaching 86.3 per 100,000 by Week 18 ending May 9, 2026, with weekly rates already down to 0.2 per 100,000 amid sharply declining national activity. This post-peak stabilization, following a season with the third-highest cumulative burden since 2010-11, positions the rate for Week 22 ending late May firmly in the 85–90 range, as additional admissions in the final weeks of surveillance are expected to remain negligible. Market-implied odds above 98% reflect this established downward trajectory from official surveillance, though an unexpected late-season uptick in transmission could still push the final cumulative figure modestly higher.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
マーケット開始日： Jun 5, 2026, 3:37 PM ET
音量
$3,638終了日
2026/06/12マーケット開始日
Jun 5, 2026, 3:37 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluSurv-NET data show the cumulative influenza-associated hospitalization rate reaching 86.3 per 100,000 by Week 18 ending May 9, 2026, with weekly rates already down to 0.2 per 100,000 amid sharply declining national activity. This post-peak stabilization, following a season with the third-highest cumulative burden since 2010-11, positions the rate for Week 22 ending late May firmly in the 85–90 range, as additional admissions in the final weeks of surveillance are expected to remain negligible. Market-implied odds above 98% reflect this established downward trajectory from official surveillance, though an unexpected late-season uptick in transmission could still push the final cumulative figure modestly higher.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
音量
$3,638終了日
2026/06/12マーケット開始日
Jun 5, 2026, 3:37 PM ETResolver
0x69c47De9D...Recent CDC FluSurv-NET data show the cumulative influenza-associated hospitalization rate reaching 86.3 per 100,000 by Week 18 ending May 9, 2026, with weekly rates already down to 0.2 per 100,000 amid sharply declining national activity. This post-peak stabilization, following a season with the third-highest cumulative burden since 2010-11, positions the rate for Week 22 ending late May firmly in the 85–90 range, as additional admissions in the final weeks of surveillance are expected to remain negligible. Market-implied odds above 98% reflect this established downward trajectory from official surveillance, though an unexpected late-season uptick in transmission could still push the final cumulative figure modestly higher.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問